What is the approximate price of a box of Sorafenib on the market?

Sorafenib/Nexavar (Sorafenib) is an oral multi-target tyrosine kinase inhibitor. It is a targeted anti-tumor drug that mainly delays the progression of cancer by inhibiting the proliferation signals and angiogenesis pathways of tumor cells. Sorafenib is widely used in the treatment of malignant tumors such as advanced liver cancer, advanced renal cell carcinoma, and differentiated thyroid cancer. In clinical practice, sorafenib is usually used as the first choice or adjuvant treatment for advanced patients who cannot be cured by surgery. Its mechanism of action mainly includes inhibiting multiple signaling pathways such as Raf kinase, VEGFR and PDGFR, thereby blocking tumor growth and angiogenesis. This multi-target mechanism allows sorafenib to maintain a certain therapeutic effect in the complex tumor microenvironment.

On the market, the original drug sorafenib has been launched in China and is included in medical insurance reimbursement. Patients can purchase it through hospitals or regular pharmacies. The common specifications of the domestic original research version are0.2g × 60 pieces, and the price is about 6,000 yuan. It is worth noting that with the development of global generic drugs, there are generic versions of sorafenib circulating in Laos, India and other regions, and the price is significantly lower than the original drug. For example, the price of generic drugs in India is about 900 yuan, while the price range of generic drugs in some overseas markets is between 500 and 1,000 yuan. These generic drugs are basically the same as the original drugs in terms of efficacy and ingredients, but have significant price advantages, providing more choices for patients with limited economic conditions.

In short, as a mature anti-tumor drug, sorafenib not only shows significant value in advanced liver cancer, kidney cancer and thyroid cancer, but its price in the market varies depending on the region and drug type. The coverage of domestic medical insurance allows patients to obtain financial support, and the emergence of generic drugs has further reduced the treatment burden and provided more patients with accessible targeted treatment options.

Reference materials:https://www.nexavar.com/